HELSINKI — Nightingale Health this week rolled out a consumer-facing blood testing service with the aim of giving people access to data to help them better manage their health.
The Finnish biotechnology firm also announced plans to raise up to €80 million ($89 million) in the coming year to support its growth, as well as partnerships with firms in Japan around deploying the new service there.
Get the full story with
360Dx Premium
Only $95 for the
first 90 days*
360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a 360Dx or GenomeWeb Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
